70842-04-5

Basic information

• Product Name: 5,5-dimethyl-3-(alpha,alpha,alpha,4-tetrafluoro-3-tolyl)hydantoin
• Synonyms: 5,5-dimethyl-3-(alpha,alpha,alpha,4-tetrafluoro-3-tolyl)hydantoin;3-(4-Fluoro-3-(Trifluoromethyl)Phenyl)-5,5-Dimethylimidazolidine-2,4-Dione;3-(4-Fluoro-3-(Trifluoromethyl)Phenyl)-5,5-Dimethylimidazolidine-2,4-Dione(WXC01722)
• CAS NO: 70842-04-5
• Molecular Formula: C₁₂H₁₀F₄N₂O₂
• Molecular Weight: 290.21
• Mol File: 70842-04-5.mol

Chemical Properties

• Appearance: /
• Density: 1.387g/cm³
• Refractive Index: 1.483
• CAS DataBase Reference: 5,5-dimethyl-3-(alpha,alpha,alpha,4-tetrafluoro-3-tolyl)hydantoin(CAS DataBase Reference)
• NIST Chemistry Reference: 5,5-dimethyl-3-(alpha,alpha,alpha,4-tetrafluoro-3-tolyl)hydantoin(70842-04-5)
• EPA Substance Registry System: 5,5-dimethyl-3-(alpha,alpha,alpha,4-tetrafluoro-3-tolyl)hydantoin(70842-04-5)

Safety Data

• Hazardous Substances Data: 70842-04-5(Hazardous Substances Data)

Usage

InChI:InChI=1/C12H10F4N2O2/c1-11(2)9(19)18(10(20)17-11)6-3-4-8(13)7(5-6)12(14,15)16/h3-5H,1-2H3,(H,17,20)

Upstream product

• 15028-41-8 methyl 2-aminoisobutyrate hydrochloride 
• 2357-47-3 4-Fluoro-3-trifluoromethylaniline 
• 77140-72-8 α,α,α,4-Tetrafluor-m-tolylcarbamidsaeurephenylester 
• 54213-21-7 α-Isocyanatobuttersaeure-methylester 
• 70842-08-9 5-Imino-4,4-dimethyl-1-(α,α,α,4-tetrafluor-m-tolyl)-2-imidazolidinon 
• 92668-50-3 2-[3-(4-Fluoro-3-trifluoromethyl-phenyl)-ureido]-2-methyl-propionic acid methyl ester 

Downstream Products

• 1179905-58-8 3-(4-fluoro-3-trifluoromethylphenyl)-5,5-dimethyl-1-(3-pentafluorosulfanyl-benzyl)imidazolidine-2,4-dione 
• 1179906-55-8 methyl 2-(3-{5-fluoro-2-[3-(4-fluoro-3-trifluoromethylphenyl)-5,5-dimethyl-2,4-dioxoimidazolidin-1-ylmethyl]phenyl}ureido)-2-methylpropionate 
• 1179804-28-4 4-{2-[3-(4-fluoro-3-trifluoromethylphenyl)-5,5-dimethyl-2,4-dioxoimidazolidin-1-ylmethyl]benzoyl}benzoic acid 
• 1179804-26-2 methyl 4-{2-[3-(4-fluoro-3-trifluoromethylphenyl)-5,5-dimethyl-2,4-dioxoimidazolidin-1-ylmethyl]benzoyl}benzoate 
• 1179329-52-2 1-{5-fluoro-2-[3-(4-fluoro-3-trifluoromethylphenyl)-5,5-dimethyl-2,4-dioxoimidazolidin-1-ylmethyl]phenyl}-3-(4-methanesulfonylphenyl)sulfamide 
• 1179329-83-9 N-{5-fluoro-2-[3-(4-fluoro-3-trifluoromethylphenyl)-5,5-dimethyl-2,4-dioxoimidazolidin-1-ylmethyl]phenyl}N'-tert-butyloxycarbonylsulfamide 
• 1179329-42-0 monoethyl [4-(3-{5-fluoro-2-[3-(4-fluoro-3-trifluoromethylphenyl)-5,5-dimethyl-2,4-dioxoimidazolidin-1-ylmethyl]phenyl}ureido)phenyl]phosphonate 
• 1179329-84-0 N-{5-fluoro-2-[3-(4-fluoro-3-trifluoromethylphenyl)-5,5-dimethyl-2,4-dioxoimidazolidin-1-ylmethyl]phenyl}sulfamide 
• 1179329-43-1 [4-(3-{5-fluoro-2-[3-(4-fluoro-3-trifluoromethylphenyl)-5,5-dimethyl-2,4-dioxoimidazolidin-1-ylmethyl]phenyl}ureido)phenyl]phosphonic acid 
• 1179329-41-9 diethyl [4-(3-{5-fluoro-2-[3-(4-fluoro-3-trifluoromethylphenyl)-5,5-dimethyl-2,4-dioxoimidazolidin-1-ylmethyl]phenyl}ureido)phenyl]phosphonate 
• 1006899-36-0 1-(2-amino-4-fluorobenzyl)-3-(4-fluoro-3-trifluoromethyl-phenyl)-5,5-dimethylimidazolidine-2,4-dione 
• 1179329-96-4 1-(4,5-dimethoxy-2-nitrobenzyl)-3-(4-fluoro-3-trifluoromethylphenyl)-5,5-dimethylimidazolidine-2,4-dione 
• 1179329-78-2 1-(4-fluoro-2-nitrobenzyl)-3-(4-fluoro-3-trifluoromethylphenyl)-5,5-dimethylimidazolidine-2,4-dione 
• 92668-58-1 5,5-Dimethyl-2,4-dioxo-3-(α,α,α,4-tetrafluor-m-tolyl)-1-imidazolidincarbonsaeureethylester 

Relevant articles and documents

Heterocycle-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising them and use thereof

The invention relates to compounds of formula (I) wherein the groups R and R′, A, D, E, G, L, p and R1 to R10 have the stated meanings and to their physiologically compatible salts. Said compounds are suitable, for example, as anti-obesity drugs.

Substituted imidazoline-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof

The invention relates to compounds of formula (I) wherein the groups R and R′, A, D, E, G, L, p and R1 to R10 have the stated meanings and to their physiologically compatible salts. Said compounds are suitable, for example, as anti-obesity drugs.

Arylchalcogenoarylalkyl-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof

The invention relates to compounds of formula (I) wherein the groups R and R′, A, D, E, G, L, p and R1 to R10 have the stated meanings and to their physiologically compatible salts. Said compounds are suitable, for example, as anti-obesity drugs.

Novel phenyl-substituted imidazolidines, process for preparation thereof, medicaments comprising said compounds and use thereof

The invention relates to compounds of formula (I) wherein the groups have stated meanings, and to their physiologically compatible salts. Said compounds are suitable, for example, as anti-obesity drugs and for treating cardiometabolic syndrome.

Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, process for preparing them, medicaments comprising these compounds, and their use

This invention relates to arylaminoaryl-alkyl-substituted imidazolidone-2,4-diones of formula (I) and also to their physiologically tolerated salts: Wherein R, R′, R1 to R10, A, D, E, G, L and p are as defined herein. The invention also relates to processes for preparing them, pharmaceutical compositions comprising them and their therapeutic use. The compounds are suitable, for example, as anti-obesity drugs and for treating cardiometabolic syndrome.

3-Arylhydantoine, a class of schistosomicidal compounds

A series of derivatives of 3-arylhydantoin was synthesized and submitted to a broad pharmacological screening. Unexpectedly, some of the tested compounds showed interesting activity against infection with Schistosoma mansoni. From a study on structure-act